Travel and the spread of HIV-1 genetic variants

Lancet Infectious Diseases

Volumn 3, Issue 1, 2003, Pages 22-27

  Perrin, Luc ^a,b   Kaiser, Laurent ^a   Yerly, Sabine ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NELFINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

EPIDEMIC; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; TRAVEL; VIRUS TRANSMISSION;

EID: 0037221414     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(03)00484-5     Document Type: Review

References (78)

1. Korber B, Muldoon M, Theiler J, et al. Timing the ancestor of the HIV-1 pandemic strains. Science 2000; 288: 1757-59.
2. Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999; 397: 436-41.
3. McCutchan FE. Understanding the genetic diversity of HIV-1. AIDS 2000; 14: S31-44.
4. Simon F, Maudere P, Roques P, et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998; 4: 1032-37.
5. Thomson MM, Perez-Alvarez L, and Najera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002; 2: 461-71.
6. Delgado E, Thomson MM, Villahermosa ML, et al. Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. J Acquir Immune Defic Syndr 2002; 5: 536-43.
7. Hirsch MS, Brun-Vezinet F, D'Aquila RT, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel. JAMA 2000; 283: 2417-26.
8. Kelleher AD, Long C, Holmes EC, et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 2001; 193: 375-86.
9. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296: 1410-11.
10. Mosaic composition of circulating recombinant forms (CRFs) of HIV-1. http://hiv-web.lanl.gov/CRFs/CRFs.html (accessed Nov 19, 2002).
11. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science 2000; 288: 55-56.
12. Zhu T, Wang N, Carr A, Wolinsky S, Ho DD. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconverter. J Virol 1995; 69: 1324-27.
13. Malim MH, Emerman M. HIV-1 sequence variation: Drift, shift, and attenuation. Cell 2001; 104: 469-72.
14. Kuiken C, Thakallapalli R, Esklid A, de Ronde A. Genetic analysis reveals epidemiologic patterns in the spread of human immunodeficiency virus. Am J Epidemiol 2000; 152: 814-22.
15. Auerbach DM, Darrow WW, Jaffe HW, Curran JW. Cluster of cases of the acquired immune deficiency syndrome. Patients linked by sexual contact. Am J Med 1984; 76: 487-92.
16. Bobkov A, Cheingsong-Popov R, Selimova L, et al. An HIV type 1 epidemic among injecting drug users in the former Soviet Union caused by a homogeneous subtype A strain. AIDS Res Hum Retroviruses 1997; 13: 1195-201.
17. Kalish ML, Baldwin A, Raktham S, et al. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: Implications for HIV vaccine trials. AIDS 1995; 9: 851-57.
18. Subbarao S, Vanichseni S, Hu DJ, et al. Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand. AIDS Res Hum Retroviruses 2000; 16: 699-707.
19. van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS 1997; 1: 113-16.
20. Jonassen TO, Stene-Johansen K, Berg ES, et al. Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s. Virology 1997; 231: 43-47.
21. Thomson MM, Najera R. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries. Clin Infect Dis 2001; 32: 1732-37.
22. Thomson MM, Delgado E, Manjón N, et al. HIV-1 genetic diversity in Galicia, Spain: BG intersubtype recombinant viruses are circulating among injecting drug users. AIDS 2001; 15: 509-16.
23. Fransen K, Buve A, Nkengasong JN, Laga M, van der Groen G. Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet 1996; 347: 1403.
24. M serotypes in French blood donors over a 10-year period (1985-1995). Retrovirus Study Group of the French Society of Blood Transfusion. AIDS 1997; 11: 1503-8.
25. Couturier E, Damond F, Roques P, et al. HIV-1 diversity in France, 1996-1998. AIDS 2000; 14: 289-96.
26. Parry JV, Murphy G, Barlow KL, et al. National surveillance of HIV-1 subtypes for England and Wales: Design, methods, and initial findings. J Acquir Immune Defic Syndr 2001; 26: 381-88.
27. Böni J, Pyra H, Gebhardt M, et al. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr 1999; 22: 174-49.
28. Weidle PJ, Ganea CE, Irwin KL, et al. Presence of human immunodeficiency virus/HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States. J Infect Dis 2000 181: 470-75.
29. Yerly S, Vora S, Rizzardi P et al. Acute HIV infection: Impact on the spread of HIV and transmission of drug resistance. AIDS 2001; 15: 2287-92.
30. McGarrigle CA, Nicoll A. Prevalence of HIV-1 among attenders at sexually transmitted disease clinics: Analyses according to country of birth. Sex Transm Infect 1998; 74: 415-20.
31. Blaxhult A, Eriksson G, Bottiger M, Lidman K. Sexually acquired HIV infections: An analysis of epidemiological data concerning cases reported in Sweden 1988-90. Scand J Infect Dis 1992; 24: 707-13.
32. Gras MJ, Weide JF, Langendam MW, Coutinho RA, van den Hoek A. HIV prevalence, sexual risk behaviour and sexual mixing patterns among migrants in Amsterdam, The Netherlands. AIDS 1999; 13: 1953-62.
33. Quinn TC. Population migration and the spread of types 1 and 2 human immunodeficiency viruses. Proc Natl Acad Sci USA 1994; 91: 2407-14.
34. Preventing HIV transmission in migrant work settings. A Research-based Field Resource Supported by The Synergy Apdime Toolkit. http://www.synergyaids.com
35. Jochelson K, Mothibeli M, Leger JP. Human immunodeficiency virus and migrant labor in South Africa. Int J Health Serv 1991; 21: 157-73.
36. Jackson DJ, Rakwar JP, Richardson BA, et al. Decreased incidence of sexually transmitted diseases among trucking company workers in Kenya: Results of a behavioural risk-reduction programme. AIDS 1997; 11: 903-09.
37. Op de Coul EL, Prins M, Cornelissen M, et al. European and Italian seroconverter studies. Using phylogenetic analysis to trace HIV-1 migration among western European injecting drug users seroconverting from 1984 to 1997. AIDS 2001; 15: 257-66.
38. Liitsola K, Tashkinova I, Laukkanen T, et al. HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad, AIDS 1998; 12: 1907-19.
39. Liitsola K, Ristola M, Holmstrom P, et al. An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population. AIDS 2000; 14: 2613-15.
40. Jost S, Yerly S, Kaufmann D, et al. Spreading of a non-B recombinant form in seroconverting IDUs. Proceedings of the 9th Conference on Retroviruses and Opportunistic Infections; 2002 Feb 24-28; Seattle, USA.
41. Gómez CE, Iglesias E, Perdomo W, et al. Isolates from four different HIV type 1 clades circulating in Cuba identified by DNA sequence of the C2-V3 region. AIDS Res Hum Retroviruses 2001; 17: 55-58.
42. Cuevas MT, Ruibal I, Villahermosa ML, et al. High HIV-1 genetic diversity in Cuba. AIDS 2002; 16: 1643-53.
43. Lasky M, Perret JL, Peeters M, et al. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 1997; 1: 43-51.
44. Brodine SK, Shaffer RA, Starkey MJ, et al. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med 1999; 131: 502-06.
45. Brodine SK, Mascola JR, Weiss PJ, et al. Detection of diverse HIV-1 genetic subtypes in the USA. Lancet 1995; 346: 1198-99.
46. Saengdidtha B, Lapparat G, Torugsa K, Suppadit W, Wakai S. Sexual behaviors and human immunodeficiency virus infection among Thai army conscripts between 1992 and 1998. Mil Med 2002; 167: 272-76.
47. Belda FJ, Barlow KL, Murphy G, Parry JV, Clewley JP. A dual subtype B/E HIV type 1 infection with a novel V3 loop crown motif among infections acquired in Thailand and imported into England. AIDS Res Hum Retroviruses 1998; 14: 911-16.
48. Dietrich U, Ruppach H, Gehring S, et al. Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors. AIDS 1997; 11: 532-33.
49. Lau JT, Thomas J. Risk behaviours of Hong Kong male residents travelling to mainland China: A potential bridge population for HIV infection. AIDS Care 2001; 13: 71-81.
50. Gillies P, Slack R, Stoddart N, Conway S. HIV-related risk behaviour in UK holiday-makers. AIDS 1992; 6: 339-41.
51. Bwayo J, Plummer F, Omari M, et al. Human immunodeficiency virus infection in long-distance truck drivers in east Africa. Arch Intern Med 1994; 154: 1391-96.
52. Lacerda R, Gravato N, McFarland W, et al. Truck drivers in Brazil: Prevalence of HIV and other sexually transmitted diseases, risk behavior and potential for spread of infection. AIDS 1997; 1: S15-9.
53. Singh YN, Malaviya AN. Long distance truck drivers in India: HIV infection and their possible role in disseminating HIV into rural areas. Int J STD AIDS 1994; 5: 137-38.
54. Gysels M, Pool R, Bwanika K. Truck drivers, middlemen and commercial sex workers: AIDS and the mediation of sex in south west Uganda. AIDS Care 2001; 13: 373-85.
55. Stratford D, Ellerbrock TV, Akins JK, Hall HL. Highway cowboys, old hands, and Christian truckers: Risk behavior for human immunodeficiency virus infection among long-haul truckers in Florida. Soc Sci Med 2000; 5: 737-49.
56. Ollero M, Pujol E, Gimeno A, Gea A, Marquez P, Iturriaga JM. Risky practices associated with HIV infection of seamen who travel in sub-Saharan West Africa. Rev Clin Esp 1991; 189: 416-21.
57. Entz AT, Ruffolo VP, Chinveschakitvanich V, Soskolne V, van Griensven GJ. HIV-1 prevalence, HIV-1 subtypes and risk factors among fishermen in the Gulf of Thailand and the Andaman Sea. AIDS 2000; 14: 1027-34.
58. Estebanez P, Sarasqueta C, Najera R, et al. Prevalence of HIV-1, HIV-2, and HTLV-I/II in Spanish seamen. J Acquir Immune Defic Syndr 1992; 5: 316-17.
59. Bonneux L, Van der Stuyft P, Taelman H, et al. Risk factors for infection with human immunodeficiency virus among European expatriates in Africa. BMJ 1988; 297; 581-84.
60. Houweling H, Coutinho RA. Risk of HIV infection among Dutch expatriates in sub-Saharan Africa. Int J STD AIDS 1991; 2: 252-57.
61. Kane F, Alary M, Ndoye I, et al. Temporary expatriation is related to HIV-1 infection in rural Senegal. AIDS 1993; 7: 1261-65.
62. Coste J, Montes B, Reynes J, et al. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Med Virol 1996; 50: 293-302.
63. Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses 1999; 15: 133-42.
64. Swanson P, Soriano V, Devare SG, Hackett J Jr. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0. J Clin Microbiol 2001; 39: 862-70.
65. Descamps D, Collin G, Letourneur F, et al. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses. J Virol 1997; 71: 8893-98.
66. Descamps D, Apetrei C, Collin G, Damond F, Simon F, Brun-Vezinet F. Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors. AIDS 1998; 12: 1109-11.
67. Shafer RW, Chuang TK, Hsu P, White CB, Katzenstein DA. Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. AIDS Res Hum Retroviruses 1999; 15: 65-69.
68. Grossman Z, Paxinos E, Auerbuch D, et al. D30N is not the preferred resistance pathway in subtype C patients treated with nelfinavir. Antiviral Therapy 2002; 7: S30.
69. Mascola JR, Louwagie J, McCutchan FE, et al. Two antigenically distinct subtypes of human immunodeficiency virus type 1: Viral genotype predicts neutralization serotype. J Infect Dis 1994; 169: 48-54.
70. van der Groen G, Nyambi PN, Beirnaert E, et al. Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development. AIDS Res Hum Retroviruses 1998; 14: S211-21.
71. Fouts T, Godfrey K, Bobb K, et al. Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques. Proc Natl Acad Sci USA 2002; 99: 11842-47.
72. Cao H, Kanki P, Sankale JL, et al. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development. J Virol 1997; 71: 8615-23.
73. Ramos A, Hu DJ, Nguyen L, et al. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002; 76: 7444-52.
74. Jost S, Bernard MC, Kaiser L, et al. A patient with HIV-1 superinfection. N Engl J Med 2002; 347: 731-36.
75. Gaschen B, Taylor J, Yusim K, et al. Diversity considerations in HIV-1 vaccine selection. Science 2002; 296: 2354-60.
76. Nelson KE, Rungruengthanakit K, Margolick J, et al. High rates of transmission of subtype E human immunodeficiency virus type 1 among heterosexual couples in Northern Thailand: Role of sexually transmitted diseases and immune compromise. J Infect Dis 1999; 180: 337-43.
77. Kanki PJ, Hamel DJ, Sankale JL, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179: 68-73.
78. Alaeus A, Lidman K, Bjorkman A, Giesecke J, Albert J. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. AIDS 1999; 13: 901-07.